Dialectic Therapeutics
PrivateLast Round
Grant
Aug 18, 2021
Total Funding Raised
$23.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Dialectic Therapeutics operates in Healthcare & Life Sciences and is based in Dallas, Texas. Its latest recorded funding round was a Grant round in August 2021.
Dialectic Therapeutics is a clinical-stage biotechnology company that develops anti-cancer drugs using its proprietary Antiapoptotic Protein Targeted Degradation (APTaD™) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dialectic Therapeutics Comparables
Compare Dialectic Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Plan Therapeutics | 77% | |
| Kymera Therapeutics, Inc. | 74% | |
| Arvinas Inc | 70% |
For institutional investors. Book with your work email.
Dialectic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 18, 2021 | ||||
| Debt | Dec 15, 2020 | ||||
| Grant | Feb 26, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dialectic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 100% MoM, from 2.3K to 4.7K.
- Jul 26, 2026
Monthly visitors increased 36% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
Dialectic Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dialectic Therapeutics's valuation, stock price, and market status.
Is Dialectic Therapeutics a public or private company?
Dialectic Therapeutics is a private company.
What is the current stock price of Dialectic Therapeutics?
Dialectic Therapeutics is a private company, so its shares have no public market price. Caplight tracks Dialectic Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dialectic Therapeutics worth (valuation)?
Valuation information for Dialectic Therapeutics is not publicly available.
Can I buy Dialectic Therapeutics stock?
Dialectic Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dialectic Therapeutics's last funding round?
Dialectic Therapeutics's most recent funding round was Grant on August 18, 2021.
Who are the main investors in Dialectic Therapeutics?
Key investors in Dialectic Therapeutics include Cancer Prevention and Research Institute of Texas (CPRIT).
Will Dialectic Therapeutics IPO soon?
No public IPO plans have been announced for Dialectic Therapeutics.
How can I track Dialectic Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Dialectic Therapeutics's shares on secondary markets.